LLMpediaThe first transparent, open encyclopedia generated by LLMs

Irwin Rose

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 54 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted54
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Irwin Rose
Irwin Rose
NameIrwin Rose
CaptionIrwin Rose in 2004
Birth date16 July 1926
Birth placeBrooklyn, New York, U.S.
Death date2 June 2015
Death placeDeerfield, Massachusetts, U.S.
FieldsBiochemistry
WorkplacesYale University, Fox Chase Cancer Center, University of California, Irvine, University of Pennsylvania
Alma materUniversity of Chicago
Known forDiscovery of ubiquitin-mediated protein degradation
PrizesNobel Prize in Chemistry (2004), Albert Lasker Award for Basic Medical Research (2000)

Irwin Rose was a distinguished American biochemist whose groundbreaking work fundamentally altered the understanding of cellular processes. He is best known for his collaborative discovery of ubiquitin-mediated protein degradation, a critical regulatory mechanism within cells. For this seminal contribution, he was awarded the Nobel Prize in Chemistry in 2004, sharing the honor with Aaron Ciechanover and Avram Hershko. His research has had profound implications for fields ranging from cell biology to the treatment of diseases like cancer and neurodegenerative disease.

Early life and education

Born in Brooklyn, he spent part of his youth in the Pacific Northwest before his family settled in Spokane. His undergraduate studies were interrupted by service in the United States Navy during World War II. After the war, he earned his Bachelor of Science degree from Washington State University in 1948. He then pursued his doctoral studies at the University of Chicago, where he worked under the guidance of biochemist Esmond E. Snell and received his Ph.D. in 1952. His early postdoctoral work was conducted at New York University School of Medicine, solidifying his foundation in enzymology.

Career and research

Rose began his independent research career at the Yale University School of Medicine, focusing on enzyme mechanisms. A pivotal turn came when he joined the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia in 1963. It was here, during a sabbatical at the Technion – Israel Institute of Technology in the late 1970s, that his collaboration with Avram Hershko and Hershko's student Aaron Ciechanover began. Their work identified a then-obscure protein, ubiquitin, and elucidated its role in a complex, ATP-dependent process that tags other proteins for destruction. This ubiquitin-proteasome system was revealed as a central controller of cell cycle progression, DNA repair, and immune response.

Nobel Prize in Chemistry

In 2004, the Royal Swedish Academy of Sciences awarded the Nobel Prize in Chemistry jointly to Rose, Ciechanover, and Hershko. The prize recognized their discovery of how the ubiquitin molecule selectively targets proteins for breakdown by the proteasome. The Nobel committee highlighted that their work unveiled a fundamental "quality control" system inside cells, crucial for normal cellular function. The award cemented the importance of their research, which had initially been met with skepticism, and underscored its wide-ranging impact on modern molecular biology and pharmaceutical development.

Later life and legacy

After leaving the Fox Chase Cancer Center in 1995, Rose continued his research at the University of California, Irvine College of Medicine. He later moved to La Jolla, maintaining an active affiliation with the University of California, San Diego. His later years were spent in Deerfield. The legacy of his work is immense, providing the mechanistic foundation for understanding the etiology of numerous diseases. The discovery of the ubiquitin-proteasome system directly led to the development of therapeutic drugs, such as bortezomib, used to treat multiple myeloma and other cancers.

Awards and honors

Throughout his career, Rose received significant recognition for his contributions to science. Prior to the Nobel, he was a co-recipient of the prestigious Albert Lasker Award for Basic Medical Research in 2000. He was elected a member of the United States National Academy of Sciences and was a fellow of the American Academy of Arts and Sciences. Other notable honors included the Wolf Prize in Medicine in 2001 and the Louisa Gross Horwitz Prize from Columbia University in 2001. He held an honorary doctorate from the Technion – Israel Institute of Technology.

Category:American biochemists Category:Nobel laureates in Chemistry Category:University of Chicago alumni